Silverarc Capital Management’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $38.1M | Sell |
|
|||||
|
2025
Q1 | $29.1M | Sell |
|
|||||
|
2024
Q4 | $20.6M | Buy |
|
|||||
|
2024
Q3 | $18.4M | Buy |
|
|||||
|
2024
Q2 | $14.7M | Buy |
|
|||||
|
2024
Q1 | $10.1M | Buy |
|
|||||
|
2023
Q4 | $5.82M | Buy |
|
|||||
|
2023
Q3 | $1.58M | Sell |
|
|||||
|
2023
Q2 | $11.3M | Buy |
|
|||||
|
2023
Q1 | $7.75M | Buy |
|
|||||
|
2022
Q4 | $9.43M | Sell |
|
|||||
|
2022
Q3 | $10.2M | Buy |
|
|||||
|
2022
Q2 | $2.46M | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $819 | Buy |
|
|||||
|
2021
Q1 | $928K | Sell |
|
|||||
|
2020
Q4 | $908K | Buy |
|